<?xml version="1.0" encoding="UTF-8"?>
<ref id="pone.0188333.ref064">
 <label>64</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Wichmann</surname>
   <given-names>O</given-names>
  </name>, 
  <name>
   <surname>Vannice</surname>
   <given-names>K</given-names>
  </name>, 
  <name>
   <surname>Asturias</surname>
   <given-names>EJ</given-names>
  </name>, 
  <name>
   <surname>de Albuquerque Luna</surname>
   <given-names>EJ</given-names>
  </name>, 
  <name>
   <surname>Longini</surname>
   <given-names>I</given-names>
  </name>, 
  <name>
   <surname>Lopez</surname>
   <given-names>AL</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>Live-attenuated tetravalent dengue vaccines: The needs and challenges of post-licensure evaluation of vaccine safety and effectiveness</article-title>. 
  <source>Vaccine</source>. 
  <year>2017</year>;
  <volume>35</volume>(
  <issue>42</issue>):
  <fpage>5535</fpage>â€“
  <lpage>42</lpage>. Epub 2017/09/13. 
  <comment>doi: 
   <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.vaccine.2017.08.066" xmlns:xlink="http://www.w3.org/1999/xlink">10.1016/j.vaccine.2017.08.066</ext-link>
  </comment> .
  <?supplied-pmid 28893477?>
  <pub-id pub-id-type="pmid">28893477</pub-id>
 </mixed-citation>
</ref>
